Bessemer Group Inc. trimmed its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 14.5% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 1,717,100 shares of the healthcare conglomerate's stock after selling 290,501 shares during the quarter. UnitedHealth Group makes up 1.6% of Bessemer Group Inc.'s holdings, making the stock its 9th largest position. Bessemer Group Inc. owned about 0.19% of UnitedHealth Group worth $899,331,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also bought and sold shares of the business. NewSquare Capital LLC bought a new position in shares of UnitedHealth Group during the 4th quarter worth approximately $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new position in UnitedHealth Group during the fourth quarter worth $26,000. Hurley Capital LLC bought a new position in shares of UnitedHealth Group in the fourth quarter valued at about $28,000. Aster Capital Management DIFC Ltd bought a new stake in shares of UnitedHealth Group during the 4th quarter worth about $30,000. Finally, Promus Capital LLC bought a new position in UnitedHealth Group in the 4th quarter valued at about $32,000. Institutional investors own 87.86% of the company's stock.
UnitedHealth Group Trading Up 2.1%
NYSE UNH traded up $6.23 on Friday, reaching $308.85. The company had a trading volume of 13,584,804 shares, compared to its average volume of 7,465,895. The firm has a market cap of $280.17 billion, a price-to-earnings ratio of 12.93, a P/E/G ratio of 1.43 and a beta of 0.44. UnitedHealth Group Incorporated has a fifty-two week low of $248.88 and a fifty-two week high of $630.73. The business has a 50 day moving average of $336.21 and a two-hundred day moving average of $454.51. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85.
UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The company had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. During the same period in the prior year, the firm earned $6.91 earnings per share. Analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
UnitedHealth Group Increases Dividend
The company also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were issued a $2.21 dividend. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date was Monday, June 16th. This represents a $8.84 annualized dividend and a yield of 2.86%. UnitedHealth Group's payout ratio is presently 37.02%.
Analysts Set New Price Targets
Several equities analysts have recently commented on UNH shares. Truist Financial reaffirmed a "buy" rating and issued a $360.00 target price (down previously from $580.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. Mizuho dropped their target price on UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating for the company in a report on Friday, May 16th. Argus downgraded shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Monday, April 21st. Bank of America downgraded shares of UnitedHealth Group from a "buy" rating to a "neutral" rating and cut their price objective for the company from $560.00 to $350.00 in a report on Wednesday, May 14th. Finally, UBS Group dropped their price target on shares of UnitedHealth Group from $400.00 to $385.00 and set a "buy" rating for the company in a research report on Wednesday. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $415.57.
Read Our Latest Report on UnitedHealth Group
Insiders Place Their Bets
In related news, CFO John F. Rex acquired 17,175 shares of UnitedHealth Group stock in a transaction dated Friday, May 16th. The stock was bought at an average price of $291.12 per share, with a total value of $4,999,986.00. Following the transaction, the chief financial officer now directly owns 203,796 shares in the company, valued at $59,329,091.52. This represents a 9.20% increase in their position. The purchase was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Kristen Gil bought 3,700 shares of the business's stock in a transaction that occurred on Thursday, May 15th. The shares were bought at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the completion of the purchase, the director now owns 3,818 shares of the company's stock, valued at $1,035,327.06. This represents a 3,135.59% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last ninety days, insiders acquired 109,408 shares of company stock worth $31,607,768. Company insiders own 0.28% of the company's stock.
UnitedHealth Group Company Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Further Reading

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report